Effects of viral load on tenofovir vs. entecavir efficacy in recurrence prevention of hepatitis B virus-related hepatocellular carcinoma.
10.1097/CM9.0000000000002433
- Author:
Weili QI
1
;
Junyi SHEN
2
;
Yu ZHANG
3
;
Fengwei GAO
4
;
Chuan LI
1
Author Information
1. Department of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
2. Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
3. Organ Transplantation Center, Sichuan Provincial People's Hospital, Chengdu, Sichuan 610072, China.
4. HBPS Diseases Center for Diagnosis and Treatment of Leshan City, People's Hospital of Leshan, Leshan, Sichuan 614000, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Tenofovir/therapeutic use*;
Carcinoma, Hepatocellular/drug therapy*;
Hepatitis B virus;
Viral Load;
Liver Neoplasms/drug therapy*;
Antiviral Agents/therapeutic use*;
Hepatitis B, Chronic/drug therapy*;
Treatment Outcome
- From:
Chinese Medical Journal
2023;136(19):2362-2364
- CountryChina
- Language:English
